billSRES807Event Tuesday, July 21, 2026Analyzed

A resolution directing the Senate Legal Counsel to bring a civil action in the name of the Senate to enforce the Foreign Emoluments Clause contained in clause 8 of section 9 of article I of the Constitution of the United States.

Neutral

Summary

SRES807 is a procedural resolution directing the Senate Legal Counsel to sue to enforce the Foreign Emoluments Clause against President Donald J. Trump. It has no direct market impact as it involves no funding, no regulatory change, and no corporate mandate. The resolution is in early stage, referred to committee, with no path to near-term enactment.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.SRES807 is a procedural resolution with zero direct market impact.
  • 2.No funding, no regulatory changes, no corporate mandates.
  • 3.Early stage, partisan, unlikely to advance in current form.

Market Implications

No market implications. The resolution does not affect any sector, company, or financial instrument. Investors should focus on bills with direct economic mechanisms.

Full Analysis

SRES807, introduced July 21, 2026, by Sen. Blumenthal (D-CT) with 14 Democratic cosponsors, is a Senate resolution directing the Senate Legal Counsel to bring a civil action to enforce the Foreign Emoluments Clause against President Donald J. Trump. The bill text alleges specific emoluments violations, including acceptance of a plane from Qatar and dealings with the United Arab Emirates. The resolution has been referred to the Committee on Rules and Administration, an early procedural stage. There is no funding authorized or appropriated—this is a legal action mechanism, not a spending bill. The resolution faces a steep legislative path: it must pass the Senate, and even if passed, it authorizes a lawsuit, not a market-moving event. No companies are named or affected. The resolution is partisan, with no Republican cosponsors, reducing its likelihood of passage in a divided Senate. Timeline: no further action scheduled; committee referral is the only step to date.

Key Legislators

Sen. Blumenthal, Richard [D-CT]

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →